[一种新型降压物质：二氯苯基氨基咪唑啉的临床及临床实验研究] - Suppr

Suppr

超能文献

[Clinical and clinical-experimental studies with a new blood pressure lowering substance: dichlorophenylaminoimidazoline].

作者信息

Bock K D, Heimsoth V, Merguet P, Schönermark J

出版信息

Dtsch Med Wochenschr. 1966 Oct 7;91(40):1761-70. doi: 10.1055/s-0028-1111588.

DOI:10.1055/s-0028-1111588

PMID:5922724

Abstract

摘要

相似文献

[Clinical and clinical-experimental studies with a new blood pressure lowering substance: dichlorophenylaminoimidazoline].

Dtsch Med Wochenschr. 1966 Oct 7;91(40):1761-70. doi: 10.1055/s-0028-1111588.

[Ophthalmological studies with dichlorophenylaminoimidazoline with special regard to its effect on intraocular pressure].

Dtsch Med Wochenschr. 1966 Sep 23;91(38):1686-8. doi: 10.1055/s-0028-1111575.

[Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].

Arzneimittelforschung. 1966 Sep;16(9):1180-3.

[Clinical studies on differential therapy of hypertension with dichlorophenylaminoimidazoline hydrochloride (Haemiton)].

Dtsch Gesundheitsw. 1970 Dec 10;25(50):2369-74.

[First observations on an antihypertensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in man].

Dtsch Med Wochenschr. 1966 Sep 2;91(35):1540-7. doi: 10.1055/s-0028-1111550.

[Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride].

Arzneimittelforschung. 1966 Sep;16(9):1174-9.

[On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].

Med Klin. 1969 May 2;64(18):842-7.

ESH-ESC guidelines for the management of hypertension.

Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3.

[Studies on the blood pressure lowering effect of cyclazenin and a cyclazenin-alpha-methyldopa combination].

Med Welt. 1969 Mar 8;10:520-6.

[Therapeutic examination and studies on renal function with a new antihypertensive agent (St 155)].

Dtsch Med Wochenschr. 1966 Sep 23;91(38):1680-6. doi: 10.1055/s-0028-1111574.

引用本文的文献

Comparison of labetalol and clonidine in hypertension.

Eur J Clin Pharmacol. 1982;21(5):363-7. doi: 10.1007/BF00542319.

Acute and chronic renal effects of guanfacine in essential and renal hypertension.

Br J Clin Pharmacol. 1980;10 Suppl 1(Suppl 1):141S-149S. doi: 10.1111/j.1365-2125.1980.tb04922.x.

Acute action of guanfacine on peripheral circulation in hypertensive patients: measurements of arterial flow of the calf and of the forefoot, of venous capacity of the calf, of the blood pressure and of the heart rate.

Br J Clin Pharmacol. 1980;10 Suppl 1(Suppl 1):115S-121S. doi: 10.1111/j.1365-2125.1980.tb04917.x.

The effects of oral clonidine on the growth hormone level in acromegalic patients.

J Endocrinol Invest. 1984 Aug;7(4):327-9. doi: 10.1007/BF03351011.

Crossover comparison of moxonidine and clonidine in mild to moderate hypertension.

Eur J Clin Pharmacol. 1984;27(2):147-52. doi: 10.1007/BF00544037.

In vitro and in vivo down-regulation of human platelet alpha 2-adrenoceptors by clonidine.

Eur J Clin Pharmacol. 1982;23(5):403-9. doi: 10.1007/BF00605989.

Behavioural and biochemical effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) on the central nervous system.

Br J Pharmacol. 1969 Feb;35(2):253-64. doi: 10.1111/j.1476-5381.1969.tb07984.x.

[On a new hypertensive agent with predominant central action, 2-(2,6-dichlorophenylamino)-2-imidazolinhydrochloride (St 155)].

Klin Wochenschr. 1968 Jan 15;46(2):77-80. doi: 10.1007/BF01747472.

Treatment of hypertension with clonidine.

Br Med J. 1970 Aug 22;3(5720):440-2. doi: 10.1136/bmj.3.5720.440.

Acute effects of clonidine on central and peripheral haemodynamics and plasma renin activity.

Eur J Clin Pharmacol. 1972 Mar;4(2):107-14. doi: 10.1007/BF00562506.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验